News
News
Inverness Medical Innovations Plans Move to NYSE
Inverness Medical Innovations, Inc., a leading provider of near-patient diagnostics, monitoring and health management solutions, announced that it intends to move the trading of its listed securities to the New York Stock Exchange (NYSE). The Company has filed its...
News
St. Jude Medical acquires Radi Medical Systems
St. Jude Medical, Inc.and Radi Medical AB announced the completion of St. Jude Medical's acquisition of Radi Medical Systems AB for $250 million in cash. St. Jude Medical, Inc.and Radi Medical AB announced the completion of St. Jude...
News
Covidien Completes Transition to New and Improved Magellan Safety Needle
Covidien, a leading global provider of healthcare products, confirmed the immediate availability of its new and improved Magellan(TM) Safety Hypodermic Needle. The modified design, which is now shipping to all customers, is in stock and available at all Covidien...
News
Boston Scientific’s express SD renal stent system approved by FDA
Boston Scientific Corporation announced that the U.S. FDA has approved the Express® SD Renal Monorail® Premounted Stent System for use as an adjunct to PTRA (percutaneous transluminal renal angioplasty) in certain lesions of the renal arteries. The Express SD...
News
Siemens sign Collaboration agreement with Hospital Clinic and Barcelona
Hospital Clinic, Barcelona and Siemens Healthcare is going to sign a unique agreement to collaborate and carry out projects integrating laboratory diagnostics, imaging and healthcare information technology to improve the management of patient care. Hospital Clinic, Barcelona and...
News
The Scientist magazine awarded Carestream Multispectral System A ‘Top 10’ Innovation for 2008
Carestream Molecular Imaging’s KODAK Multispectral Imaging System earned the “Top 10 Innovations of 2008” award from The Scientist magazine. A panel of expert judges evaluated a broad range of life science technologies to determine the year’s top innovations, with...
News
ev3 Inc. received FDA clearance to Market EverCross 0.035 and NanoCross 0.014
ev3 Inc., a global endovascular device company, announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) to market its EverCross 0.035 and NanoCross 0.014 peripheral angioplasty balloon catheters. ev3 expects to begin full...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
